Research Associate 2 or 3 - IID

Located in the beautiful Hudson Valley region of New York, Regeneron is a biopharmaceutical Company that discovers, develops, and commercializes therapeutic medicines for the treatment of serious medical conditions. Regeneron currently markets ARCALYST™ (rilonacept) Injection for subcutaneous use for the treatment of a rare, inherited, inflammatory condition. The company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases and inflammatory diseases, and has preclinical programs in other diseases and disorders.

With a strong research base and product focus, Regeneron is able to understand thoroughly the biology of specific disease states, discover potential therapeutic candidates and evaluate product candidates in clinical trials. Regeneron has developed several proprietary platform technologies, which it has incorporated into a comprehensive system that allows it to accelerate the discovery and design of fully human antibodies and move these candidates rapidly into clinical development.

 

We are seeking a self-motivated research associate to join our team in the immune & inflammatory disease group. This group evaluates and identifies Monoclonal Antibodies and other protein therapeutic targets for Regeneron. As a member of this group, this position will support research and development efforts in small animal models of human diseases. The candidate will work closely with the in vivo biology research.

 

Qualified candidates require extensive training in molecular biology methods, good organizational skills and an ability to work and collaborate with others in a must. Verbal and writing skills are also important.  Prior experiences with plasmid vector construction, PCR based assays, and cell based bioassays are highly desirable.

A working experience with mice is highly desirable.

 

Please send resumes to: tonya.zerr@kenexa.com